Journal of Cardiac Failure
Volume 13, Issue 5 , Pages 372-379 , June 2007

Usefulness of Delayed Enhancement Magnetic Resonance Imaging to Differentiate Dilated Phase of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy

  • Fumitaka Matoh, MD

      Affiliations

    • From the Department of Emergency Medicine
    • ,
  • Hiroshi Satoh, MD, PhD

      Affiliations

    • Division of Cardiology, Internal Medicine III
    • Corresponding Author InformationReprint requests: Hiroshi Satoh, MD, PhD, Internal Medicine III, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
    • ,
  • Katsunori Shiraki, MD

      Affiliations

    • Division of Cardiology, Internal Medicine III
    • ,
  • Takeji Saitoh, MD

      Affiliations

    • Division of Cardiology, Internal Medicine III
    • ,
  • Tsuyoshi Urushida, MD

      Affiliations

    • Division of Cardiology, Internal Medicine III
    • ,
  • Hideki Katoh, MD, PhD

      Affiliations

    • Division of Cardiology, Internal Medicine III
    • ,
  • Yasuo Takehara, MD, PhD

      Affiliations

    • Department of Radiology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Harumi Sakahara, MD, PhD

      Affiliations

    • Department of Radiology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Hideharu Hayashi, MD, PhD

      Affiliations

    • Division of Cardiology, Internal Medicine III

Received 17 October 2006 ,Revised 2 February 2007 ,Accepted 5 February 2007.

References 

  1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–1320
  2. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114:216–225
  3. Varnava AM, Elliott PM, Baboonian C, Davison F, Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation. 2001;104:1380–1384
  4. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775–785
  5. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JAC. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 2002;106:1083–1089
  6. van Hoe L, Vanderheyden M. Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. Am J Roentgenol. 2004;182:95–100
  7. Wagner A, Mahrholdt H, Holly TA, Elliot MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–379
  8. Matoh F, Hayashi H, Terada H, Satoh H, Katoh H, Urushida T, et al. Usefulness of delayed enhancement magnetic resonance imaging for detecting cardiac rupture caused by small myocardial infarction in a case of cardiac tamponade. Circ J. 2005;69:1556–1559
  9. Wilson JM, Villareal RP, Hariharan R, Massumi A, Muthupillai R, Flamm SD. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J. 2002;29:176–180
  10. Bogaert J, Goldstein M, Tannouri F, Golzarian J, Dymarkowski S. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. Am J Roentgenol. 2003;180:981–985
  11. Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M, et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging. 2004;22:155–161
  12. Amano Y, Takayama M, Takahama K, Kumazaki T. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances. J Magn Reson Imaging. 2004;20:595–600
  13. Matsunaka T, Hamada M, Matsumoto Y, Higaki J. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI. Magn Reson Med Sci. 2003;2:61–69
  14. Moon JCC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennel DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561–1567
  15. Knaapen P, van Dockum WG, Bondarenko O, Kok WE, Gotte MJ, Boellaard R, et al. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med. 2005;46:923–929
  16. Koito H, Suzuki J, Ohkubo N, Ishiguro Y, Iwasaki T, Inada M. Gadolinium-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging of dilated cardiomyopathy: clinical significance of abnormally high signal intensity of left ventricular myocardium. J Cardiol. 1996;28:41–49
  17. Akisawa M, Matsumura Y, Kitaoka H, Yamasaki N, Takata J, Doi Y. Myocardial enhancement on magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy. J Cardiol. 2002;40:145–152
  18. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–59
  19. Zimmermann O, Grebe O, Merkle N, Nusser T, Kochs M, Bienek-Ziolkowski M, et al. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail. 2006;8:162–166
  20. Richardson C, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841–842
  21. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol. 1993;22:1455–1464
  22. Edelman RR. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology. 2004;232:653–668
  23. Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S, et al. Delayed hyperenhancement: frequent finding in magnetic resonance imaging of left ventricular hypertrophy due to aortic stenosis and hypertrophic cardiomyopathy. Heart. 2006;92:1447–1451
  24. Kuribayashi T, Roberts WC. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70:1333–1340
  25. Yutani C, Imakita M, Ishibashi-Ueda H, Hatanaka K, Nagata S, Sakakibara H, et al. Three autopsy cases of progression to left ventricular dilation in patients with hypertrophic cardiomyopathy. Am Heart J. 1985;109:545–553
  26. Iida K, Yutani C, Imakita M, Ishibashi-Ueda H. Comparison of percentage area of myocardial fibrosis and disarray in patients with classical form and dilated phase of hypertrophic cardiomyopathy. J Cardiol. 1998;32:173–180
  27. Moon JCC, Emma R, Sheppard MN, Elkington AG, Ho SY, Burke M, et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;43:2260–2264
  28. Chien KR. Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies. J Clinical Invest. 2003;111:175–178
  29. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855–861
  30. Moon JCC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004;90:645–649
  31. Tseng WY, Dou J, Reese TG, Wedeen VJ. Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI. J Magn Reson Imaging. 2006;23:1–8

PII: S1071-9164(07)00029-2

doi: 10.1016/j.cardfail.2007.02.001

Journal of Cardiac Failure
Volume 13, Issue 5 , Pages 372-379 , June 2007

Article Tools

* Image Usage & Resolution